Cryosite Ltd (CTE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cryosite Ltd (CTE) has a cash flow conversion efficiency ratio of 0.361x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$1.30 Million ≈ $921.96K USD) by net assets (AU$3.61 Million ≈ $2.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Cryosite Ltd (CTE) defensive interval to measure how many days the company can operate on defensive assets alone.
Cryosite Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Cryosite Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Cryosite Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cryosite Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yukselen Celik As
IS:YKSLN
|
0.232x |
|
Smr Utama Tbk
JK:SMRU
|
0.656x |
|
Bluerock Homes Trust Inc.
NYSE MKT:BHM
|
0.021x |
|
Yesil Yapi Endustrisi AS
IS:YYAPI
|
0.001x |
|
Hi Sharp Electronics Co Ltd
TWO:3128
|
-0.015x |
|
HYUNDAI BIOLAND Co.Ltd
KQ:052260
|
0.102x |
|
Jaba I Inversiones Inmobiliarias Socimi SA
MC:YABA
|
0.001x |
|
Excelsior Biopharma
TWO:6496
|
-0.028x |
Annual Cash Flow Conversion Efficiency for Cryosite Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Cryosite Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see CTE market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$2.39 Million ≈ $1.69 Million |
AU$2.06 Million ≈ $1.46 Million |
0.864x | -54.36% |
| 2024-06-30 | AU$1.45 Million ≈ $1.03 Million |
AU$2.74 Million ≈ $1.94 Million |
1.893x | +274.03% |
| 2023-06-30 | AU$2.78 Million ≈ $1.97 Million |
AU$1.41 Million ≈ $996.25K |
0.506x | -62.25% |
| 2022-06-30 | AU$1.86 Million ≈ $1.32 Million |
AU$2.49 Million ≈ $1.77 Million |
1.341x | +130.27% |
| 2021-06-30 | AU$819.23K ≈ $579.65K |
AU$476.96K ≈ $337.48K |
0.582x | -93.10% |
| 2020-06-30 | AU$154.88K ≈ $109.58K |
AU$1.31 Million ≈ $924.35K |
8.435x | +2135.42% |
| 2019-06-30 | AU$-1.72 Million ≈ $-1.21 Million |
AU$-647.54K ≈ $-458.17K |
0.377x | +379.99% |
| 2018-06-30 | AU$1.94 Million ≈ $1.38 Million |
AU$-261.91K ≈ $-185.32K |
-0.135x | -126.08% |
| 2017-06-30 | AU$3.15 Million ≈ $2.23 Million |
AU$1.63 Million ≈ $1.15 Million |
0.517x | +267.77% |
| 2016-06-30 | AU$3.38 Million ≈ $2.39 Million |
AU$474.61K ≈ $335.82K |
0.140x | -64.86% |
| 2015-06-30 | AU$3.54 Million ≈ $2.51 Million |
AU$1.42 Million ≈ $1.00 Million |
0.400x | +54.74% |
| 2014-06-30 | AU$6.14 Million ≈ $4.34 Million |
AU$1.58 Million ≈ $1.12 Million |
0.258x | -16.57% |
| 2013-06-30 | AU$6.26 Million ≈ $4.43 Million |
AU$1.94 Million ≈ $1.37 Million |
0.310x | -9.74% |
| 2012-06-30 | AU$5.48 Million ≈ $3.88 Million |
AU$1.88 Million ≈ $1.33 Million |
0.343x | +13.39% |
| 2011-06-30 | AU$4.69 Million ≈ $3.32 Million |
AU$1.42 Million ≈ $1.00 Million |
0.303x | +34.76% |
| 2010-06-30 | AU$4.35 Million ≈ $3.08 Million |
AU$977.66K ≈ $691.75K |
0.225x | +37.27% |
| 2009-06-30 | AU$4.34 Million ≈ $3.07 Million |
AU$709.86K ≈ $502.27K |
0.164x | -20.44% |
| 2008-06-30 | AU$4.32 Million ≈ $3.06 Million |
AU$888.27K ≈ $628.51K |
0.206x | +10.08% |
| 2007-06-30 | AU$3.74 Million ≈ $2.64 Million |
AU$697.65K ≈ $493.63K |
0.187x | +358.76% |
| 2006-06-30 | AU$2.81 Million ≈ $1.99 Million |
AU$-203.02K ≈ $-143.65K |
-0.072x | +10.55% |
| 2005-06-30 | AU$2.48 Million ≈ $1.75 Million |
AU$-199.90K ≈ $-141.44K |
-0.081x | +66.81% |
| 2004-06-30 | AU$3.04 Million ≈ $2.15 Million |
AU$-738.72K ≈ $-522.69K |
-0.243x | +20.88% |
| 2002-06-30 | AU$3.89 Million ≈ $2.75 Million |
AU$-1.20 Million ≈ $-845.61K |
-0.307x | -27.31% |
| 2001-06-30 | AU$3.87 Million ≈ $2.74 Million |
AU$-933.52K ≈ $-660.52K |
-0.241x | -- |
About Cryosite Ltd
Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial … Read more